You are viewing the site in preview mode

Skip to main content

Advertisement

Table 1 Virological and clinical characteristics of patients with hepatitis C virus infection

From: Core mutations, IL28B polymorphisms and response to peginterferon/ribavirin treatment in Swedish patients with hepatitis C virus genotype 1 infection

      Core amino acid   
Patient no Genotype Viral load (106 IU/ml) Sex Age (years) 70 91 rs12979860 End of treatment response a
R1 1a 4.36 M 52.6 R C CC SVR
R2 1a 6.37 M 34.9 R C CC SVR
R3 1a 7.84 M 45.8 R C CC SVR
R4 1a 7.77 F 42.3 R C CC SVR
R5 1a 7.05 M 45.3 R C CC SVR
R6 1a 7.19 F 45.5 R C CC SVR
R7 1a 5.54 F 46.9 R C CC SVR
R8 1a 5.46 M 29.1 R C CT SVR
R9 1a 6.18 M 50.7 R C CC SVR
R10 1a 6.42 M 59.9 R C CC SVR
R11 1a 5.85 M 46.4 R C CC SVR
R12 1a 7.25 M 36.4 R C CT SVR
R13 1a 6.43 M 57.5 R C CC SVR
R14 1a 6.06 M 39.2 R C CT SVR
R15 1a 6.63 F 47.1 R C CT SVR
R21 1a 5.36 F 29.6 R C CT SVR
R22 1a 5.55 F 28.7 R C CT SVR
R23 1a 6.43 F 41.2 R C CC SVR
R24 1a 6.10 M 51.3 R C CC SVR
R25 1a 7.49 F 55.7 R C CC SVR
R28 1a 7.79 M 41.5 R C CT SVR
N1 1a 6.28 M 40.5 R C CT non-SVR
N2 1a 6.25 M 50.3 R C CT non-SVR
N3 1a 6.10 M 55.9 R C TT non-SVR
N4 1a 7.05 M 47.9 R C TT non-SVR
N5 1a 5.89 M 50.8 R C CT non-SVR
N6 1a 6.42 F 48.1 P C CT non-SVR
N7 1a 6.72 M 48.9 R C TT non-SVR
N8 1a 7.35 M 54.6 R C TT non-SVR
N9 1a 6.13 F 57.8 R C TT non-SVR
N10 1a 6.72 M 54.6 R C TT non-SVR
N11 1a 6.42 M 48.0 R C CT non-SVR
N12 1a 7.32 F 48.4 R C CT non-SVR
N13 1a 6.09 M 24.3 R C TT non-SVR
N14 1a 6.31 M 35.0 R C CT non-SVR
N20 1a 6.73 F 35.0 R C CC non-SVR
N21 1a 7.15 F 45.0 R C CC non-SVR
R16 1b 4.13 F 46.5 R M CC SVR
R17 1b 4.94 M 31.5 R M CC SVR
R18 1b 5.40 F 58.7 R M CT SVR
R19 1b 6.23 F 38.4 R L CT SVR
R20 1b 7.39 F 47.8 R M CT SVR
R26 1b 7.17 M 46.6 R L CT SVR
R27 1b 6.81 M 56.8 R M CT SVR
R29 1b 7.55 M 57.0 Q M CT SVR
N15 1b 6.08 F 56.5 Q M CT non-SVR
N16 1b 6.57 F 58.5 Q M TT non-SVR
N17 1b 7.37 M 48.9 Q L CT non-SVR
N18 1b 6.69 M 62.8 Q L CT non-SVR
N19 1b 6.70 F 54.2 Q M CT non-SVR
  1. aSVR, sustained virologic response; non-SVR, no sustained virologic response